Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the company will increase the manufacturing capacity of new and existing medications. Main disease areas include cardio-renal-metabolic (CRM) diseases, mental health, pulmonary fibrosis,
A liquid compression system prototype at General Fusion’s Canadian labs RICHMOND, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) — General Fusion has published new, peer-reviewed scientific results that validate the company has achieved the smooth, rapid, and symmetric compression of a liquid cavity that is key to the design of
REGENETEN Patch 2024 First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently completed randomized controlled trial (RCT). Published online in Arthroscopy in December, […]
Quantexa to provide category-leading AI-enabled technology, training, and industry expertise to ATII to improve how data is used in the identification and investigation of human trafficking NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Today, Quantexa, a global leader in Decision Intelligence (DI) solutions for the public and private sectors,
Argentina’s Central Securities Depository (CSD) has successfully launched its new technology platform Rapidly accelerated launch timetable secures the platform’s ability to meet significant increase in volumes BUENOS AIRES, Argentina and NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Caja de Valores, Argentina’s Central Securities Depository (CSD), today announced it has
Onshore wind project Hatalageri in the State of Karnataka, India, is the first project from CIP’s partnership with Viviid Renewables to reach final investment decision. COPENHAGEN, Denmark, Jan. 11, 2024 (GLOBE NEWSWIRE) — Copenhagen Infrastructure Partners (CIP) through its Growth Markets Fund I (CI GMF I) has taken final investment